REPORTS

Let’s Pullulate and Expand Your Business

Remicade Biosimilar Market - Global Professional Analysis and Forecast to 2026

Jan 17, 2020  |  217 PAGES  |  REPORT CODE: CMM261949
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Remicade Biosimilar market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.2% during the forecast period.

This report presents the market size and development trends by detailing the Remicade Biosimilar market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Remicade Biosimilar market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Remicade Biosimilar industry and will help you to build a panoramic view of the industrial development.

Remicade Biosimilar Market, By Type:

  • 100mg/10ml

  • 500mg/50ml

Remicade Biosimilar Market, By Application:

  • Blood Disorders

  • Oncology Diseases

Some of the leading players are as follows:

  • Celltrion

  • Merck Serono (Merck Group)

  • Novartis (Sandoz)

  • Biogen idec Inc.

  • Biocon

  • Hospira

  • Genentech (Roche Group)

  • LG Life Sciences

  • Synthon Pharmaceuticals

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Remicade Biosimilar Market: Technology Type Analysis

  • 4.1 Remicade Biosimilar Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Remicade Biosimilar Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 100mg/10ml

    • 4.3.2 500mg/50ml

5 Remicade Biosimilar Market: Product Analysis

  • 5.1 Remicade Biosimilar Product Market Share Analysis, 2018 & 2026

  • 5.2 Remicade Biosimilar Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Remicade Biosimilar Market: Application Analysis

  • 6.1 Remicade Biosimilar Application Market Share Analysis, 2018 & 2026

  • 6.2 Remicade Biosimilar Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Blood Disorders

    • 6.3.2 Oncology Diseases

7 Remicade Biosimilar Market: Regional Analysis

  • 7.1 Remicade Biosimilar Regional Market Share Analysis, 2018 & 2026

  • 7.2 Remicade Biosimilar Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Celltrion

    • 9.1.1 Celltrion Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Merck Serono (Merck Group)

    • 9.2.1 Merck Serono (Merck Group) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis (Sandoz)

    • 9.3.1 Novartis (Sandoz) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Biogen idec Inc.

    • 9.4.1 Biogen idec Inc. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Biocon

    • 9.5.1 Biocon Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Hospira

    • 9.6.1 Hospira Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Genentech (Roche Group)

    • 9.7.1 Genentech (Roche Group) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 LG Life Sciences

    • 9.8.1 LG Life Sciences Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Synthon Pharmaceuticals

    • 9.9.1 Synthon Pharmaceuticals Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

 

The List of Tables and Figures (Totals 74 Figures and 165 Tables)

  • Figure 100mg/10ml Remicade Biosimilar market, 2015 - 2026 (USD Million)

  • Figure 500mg/50ml Remicade Biosimilar market, 2015 - 2026 (USD Million)

  • Figure Blood Disorders market, 2015 - 2026 (USD Million)

  • Figure Oncology Diseases market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Remicade Biosimilar market, by country, 2015 - 2026 (USD Million)

  • Table North America Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table North America Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table North America Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Canada Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Canada Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Europe Remicade Biosimilar market, by country, 2015 - 2026 (USD Million)

  • Table Europe Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Europe Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Europe Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Germany Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Germany Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table France Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table France Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Italy Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Italy Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Spain Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Spain Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Remicade Biosimilar market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table China Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table China Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Japan Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Japan Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table India Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table India Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Remicade Biosimilar market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table MEA Remicade Biosimilar market, by country, 2015 - 2026 (USD Million)

  • Table MEA Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table MEA Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table MEA Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Remicade Biosimilar market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Remicade Biosimilar market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Remicade Biosimilar market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Celltrion Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Serono (Merck Group) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis (Sandoz) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biogen idec Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biocon Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hospira Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genentech (Roche Group) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LG Life Sciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Synthon Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top